- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 164
Belluscura harnesses Nanotether Discovery Science
Cardiff spinout Nanotether Discovery Science has been acquired for $340,000.
Apr 28, 2017SiriusXM goes Automatic in $100m acquisition
The online radio group has bought in-car connected technology developer Automatic Labs, giving exits to Comcast, CDK Global and USAA among others.
Apr 28, 2017Yik Yak gets Square deal in $3m acqui-hire
Square has reportedly paid $3m for the engineering team of microblogging platform Yik Yak, likely signalling the Renren-backed company is nearing the end of the line.
Apr 26, 2017TeleSign signals Telstra exit through $230m acquisition
Bics has agreed to acquire TeleSign, which raised $49m in a 2014 Telstra-backed series B round, to form the world's first end-to-end communications-platform-as-a-service provider.
Apr 26, 2017Microsoft to commission Cloudyn acquisition
Microsoft could pay up to $70m for the cloud optimisation platform, which has raised more than $20m in funding including $4m from Infosys last August.
Apr 25, 2017Moat to form part of Oracle's structure
Oracle has agreed to acquire Moat, which had raised $67m since 2010 from backers including SoftBank Capital, for a reported $850m.
Apr 20, 2017Walmart to iron out $300m Bonobos acquisition
Nordstrom and Coppel could exit the online men's fashion company, which is in talks with Walmart over an acquisition that would follow $127m of venture funding.
Apr 18, 2017PetCoach gets a new owner
Petco has purchased petcare services platform PetCoach for an undisclosed sum, providing an exit to corporate investors Comcast and Pet360.
Apr 5, 2017Grab pays up to $100m for Kudo
Grab has completed the acquisition of Emtek, Gree and Singapore Press Holdings-backed mobile payment portal Kudo for between $80m and $100m.
Apr 5, 2017Vtesse accelerates to $200m acquisition
Sucampo has acquired the Lundbeck and Pfizer-backed rare diseases treatment developer for $200m in stock and cash, less than a year after it closed a $42m series A round.
Apr 4, 2017About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


